Use of covered stents to occlude extracardiac Fontan fenestration;Utilisation de stents couverts pour la fermeture des fenestrations extracardiaques des dérivations cavopulmonaires totales

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 5, 2006, Pages 424-428

  Boudjemline, Younes ^a   Agnoletti, G ^b   Marini, D ^b   Bonnet, D ^b   Sidi, D ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; ARTICLE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CORONARY STENT; FEMORAL VEIN; FENESTRATION; FONTAN PROCEDURE; HUMAN; JUGULAR VEIN; OXYGEN SATURATION; SHUNTING; STENT; ADOLESCENT; CHILD; CONGENITAL HEART MALFORMATION; FOLLOW UP; HEART CATHETERIZATION; METHODOLOGY; PROSTHESIS; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; FEMORAL VEIN; FOLLOW-UP STUDIES; FONTAN PROCEDURE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; JUGULAR VEINS; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; STENTS;

EID: 33748751009     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. van Doom CA, de Leval MR. The Fontan operation in clinical practice: indications and controversies. Nat Clin Pract Cardiovasc Med 2005;2:116-7.
2. Fishberger SB, Wernovsky G, Gentles TL, et al. Factors that influence the development of atrial flutter after the Fontan operation. J Thorac Cardiovasc Surg 1997;113:80-6.
3. Lemler MS, Scott WA, Leonard SR, Stromberg D, Ramaciotti C. Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 2002;105:207-11
4. Quinones JA, Deleon SY, Bell TJ, et al. Fenestrated Fontan procedure: evolution of technique and occurrence of paradoxical embolism. Pediatr Cardiol 1997;18:218-21.
5. Goff DA, Blume ED, Gauvreau K, Mayer JE, Lock JE, Jenkins KJ. Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. Circulation 2000;102:2094-9.
6. Ruiz CE, Austin EH 3rd, Cheatham JP, et al. First FDA approval under humanitarian device exemption of a septal occluder for fenestrated Fontan and muscular ventricular septal defects. Catheter Cardiovasc Interv 2000;50:159.
7. Moore JW, Murdison KA, Baffa GM, Kashow K, Murphy JD. Transcatheter closure of fenestrations and excluded hepatic veins after Fontan: versatility of the Amplatzer device. Am Heart J 2000;140:534-40.
8. Rueda F, Squitieri C, Ballerini L. Closure of the fenestration in the extracardiac Fontan with the Amplatzer duct occluder device. Catheter Cardiovasc Interv 2001;54:88-92.
9. Bradley TJ, Human DG, Culham JA, et al. Clipped tube fenestration after extracardiac Fontan allows for simple transcatheter coil occlusion. Ann Thorac Surg 2003;76:1923-8.
10. Kane A, Godart F, Rey C, Breviere GM, Vaksmann G, Francart C. Résultats à court et moyen terme des dérivations cavopulmonaires. Arch Mal Cœur 1998;91:553-60.
11. Boudjemline Y, Bonnet D, Sidi D, Agnoletti G. Fermeture percutanée à l'aide de l'Amplatzer duct occluder des fenestrations extracardiaques des dérivations cavopulmonaires totales. Arch Mal Cœur 2005;98:449-54.
12. Barrio J, Ripoll C, Banares R, et al. Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents. Eur J Radiol 2005;55:120-4.
13. Melissano G, Civilini E, Bertoglio L, Setacci F, Chiesa R. Endovascular treatment of aortic arch aneurysms. Eur J Vasc Endovasc Surg 2005;29:131-8.